187 related articles for article (PubMed ID: 21954124)
1. Phase contrast MRI is an early marker of micrometastatic breast cancer development in the rat brain.
Budde MD; Gold E; Jordan EK; Smith-Brown M; Frank JA
NMR Biomed; 2012 May; 25(5):726-36. PubMed ID: 21954124
[TBL] [Abstract][Full Text] [Related]
2. Quantitative T2* imaging of metastatic human breast cancer to brain in the nude rat at 3 T.
Song HT; Jordan EK; Lewis BK; Gold E; Liu W; Frank JA
NMR Biomed; 2011 Apr; 24(3):325-34. PubMed ID: 20949637
[TBL] [Abstract][Full Text] [Related]
3. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
[TBL] [Abstract][Full Text] [Related]
4. Multiparametric characterization of response to anti-angiogenic therapy using USPIO contrast-enhanced MRI in combination with dynamic contrast-enhanced MRI.
Kim J; Kim E; Euceda LR; Meyer DE; Langseth K; Bathen TF; Moestue SA; Huuse EM
J Magn Reson Imaging; 2018 Jun; 47(6):1589-1600. PubMed ID: 29205621
[TBL] [Abstract][Full Text] [Related]
5. Investigating intracranial tumour growth patterns with multiparametric MRI incorporating Gd-DTPA and USPIO-enhanced imaging.
Boult JK; Borri M; Jury A; Popov S; Box G; Perryman L; Eccles SA; Jones C; Robinson SP
NMR Biomed; 2016 Nov; 29(11):1608-1617. PubMed ID: 27671990
[TBL] [Abstract][Full Text] [Related]
6. Multi-modal imaging of angiogenesis in a nude rat model of breast cancer bone metastasis using magnetic resonance imaging, volumetric computed tomography and ultrasound.
Bäuerle T; Komljenovic D; Berger MR; Semmler W
J Vis Exp; 2012 Aug; (66):e4178. PubMed ID: 22929330
[TBL] [Abstract][Full Text] [Related]
7. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
8. Differential microstructure and physiology of brain and bone metastases in a rat breast cancer model by diffusion and dynamic contrast enhanced MRI.
Budde MD; Gold E; Jordan EK; Frank JA
Clin Exp Metastasis; 2012 Jan; 29(1):51-62. PubMed ID: 22042553
[TBL] [Abstract][Full Text] [Related]
9. Breast cancers: MR imaging of folate-receptor expression with the folate-specific nanoparticle P1133.
Meier R; Henning TD; Boddington S; Tavri S; Arora S; Piontek G; Rudelius M; Corot C; Daldrup-Link HE
Radiology; 2010 May; 255(2):527-35. PubMed ID: 20413763
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of tumour vasculature in mouse brain by USPIO contrast-enhanced MRI.
Gambarota G; Leenders W; Maass C; Wesseling P; van der Kogel B; van Tellingen O; Heerschap A
Br J Cancer; 2008 Jun; 98(11):1784-9. PubMed ID: 18506183
[TBL] [Abstract][Full Text] [Related]
11. Longitudinal MRI evaluation of intracranial development and vascular characteristics of breast cancer brain metastases in a mouse model.
Zhou H; Chen M; Zhao D
PLoS One; 2013; 8(4):e62238. PubMed ID: 23638013
[TBL] [Abstract][Full Text] [Related]
12. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
[TBL] [Abstract][Full Text] [Related]
13. Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.
Bhujwalla ZM; Artemov D; Natarajan K; Ackerstaff E; Solaiyappan M
Neoplasia; 2001; 3(2):143-53. PubMed ID: 11420750
[TBL] [Abstract][Full Text] [Related]
14. Decrease in tumor apparent permeability-surface area product to a MRI macromolecular contrast medium following angiogenesis inhibition with correlations to cytotoxic drug accumulation.
Daldrup-Link HE; Okuhata Y; Wolfe A; Srivastav S; Øie S; Ferrara N; Cohen RL; Shames DM; Brasch RC
Microcirculation; 2004; 11(5):387-96. PubMed ID: 15280064
[TBL] [Abstract][Full Text] [Related]
15. Vasculature-specific MRI reveals differential anti-angiogenic effects of a biomimetic peptide in an orthotopic breast cancer model.
Kim E; Lee E; Plummer C; Gil S; Popel AS; Pathak AP
Angiogenesis; 2015 Apr; 18(2):125-36. PubMed ID: 25408417
[TBL] [Abstract][Full Text] [Related]
16. Permeability to macromolecular contrast media quantified by dynamic MRI correlates with tumor tissue assays of vascular endothelial growth factor (VEGF).
Cyran CC; Sennino B; Fu Y; Rogut V; Shames DM; Chaopathomkul B; Wendland MF; McDonald DM; Brasch RC; Raatschen HJ
Eur J Radiol; 2012 May; 81(5):891-6. PubMed ID: 21889860
[TBL] [Abstract][Full Text] [Related]
17. In vivo "MRI phenotyping" reveals changes in extracellular matrix transport and vascularization that mediate VEGF-driven increase in breast cancer metastasis.
Pathak AP; McNutt S; Shah T; Wildes F; Raman V; Bhujwalla ZM
PLoS One; 2013; 8(5):e63146. PubMed ID: 23650550
[TBL] [Abstract][Full Text] [Related]
18. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
19. MRI monitoring of tumor response following angiogenesis inhibition in an experimental human breast cancer model.
Turetschek K; Preda A; Floyd E; Shames DM; Novikov V; Roberts TP; Wood JM; Fu Y; Carter WO; Brasch RC
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):448-55. PubMed ID: 12722742
[TBL] [Abstract][Full Text] [Related]
20. Noninvasive Imaging of Liposomal Delivery of Superparamagnetic Iron Oxide Nanoparticles to Orthotopic Human Breast Tumor in Mice.
Kato Y; Zhu W; Backer MV; Neoh CC; Hapuarachchige S; Sarkar SK; Backer JM; Artemov D
Pharm Res; 2015 Nov; 32(11):3746-3755. PubMed ID: 26078000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]